Follows people newly diagnosed with relapsing multiple sclerosis over time
Follows people with relapsing multiple sclerosis over 5 and 10 years.
Plain-language title generated from the registry record
Registry title: Multiple Sclerosis: FutureMS-2 - an Observational Cohort and Scottish Precision Medicine Study
Key facts
- Where
- Aberdeen, Dundee, Edinburgh, Glasgow, and Inverness, United KingdomSee the 5 sites
Where in United Kingdom
- Aberdeen Clinical Research Facility Royal Cornhill HospitalAberdeen, United KingdomNo longer taking part
- Dundee Clinical Research Centre Ninewells HospitalDundee, United KingdomNo longer taking part
- Anne Rowling Regenerative Neurology ClinicEdinburgh, United KingdomNo longer taking part
- Glasgow Clinical Research Facility Queen Elizabeth University HospitalGlasgow, United KingdomNo longer taking part
- Centre for Health Sciences Raigmore HospitalInverness, United KingdomNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Edinburgh
- Trial code
- NCT06001138
- Record updated
- 13 May 2026
- Original description
FutureMS is a project created in direct response to frequent questions people with MS ask their doctors. Every person newly diagnosed wants to know how MS will affect them over their life and what can be done to stop the disease progressing and improve their quality of life. FutureMS aims to help answer those questions.Read full original descriptionShow less
FutureMS-2: Clinical, Laboratory, and Genomic Predictors of Disease Activity in People Diagnosed With Relapsing Onset Multiple Sclerosis: an Observational Cohort and Scottish Precision Medicine Study
FutureMS is a project created in direct response to frequent questions people with MS ask their doctors. Every person newly diagnosed wants to know how MS will affect them over their life and what can be done to stop the disease progressing and improve their quality of life. FutureMS aims to help answer those questions.
The original FutureMS study provided a snapshot of the impact of MS within a year of diagnosis. However, MS is a long-term condition and so the investigators now want to better understand the impact of MS, on the same individuals, after approximately 5 and 10 years of living with MS. This is the purpose of FutureMS-2.
Inclusion: Previous participants in FutureMS cohort; Capacity to provide informed consent.
Exclusion: Not a participant of FutureMS inception cohort; Contraindication to MR brain imaging.